Olavex 5/Olavex 10

Olavex 5/Olavex 10 Adverse Reactions

olanzapine

Manufacturer:

Vexxa Lifesciences

Distributor:

VE Pharma
Full Prescribing Info
Adverse Reactions
Blood and the lymphatic system disorders: Eosinophilia, Leukopenia, Neutropenia, Thrombocytopenia.
Immune system disorders: Hypersensitivity.
Metabolism and nutrition disorders: Weight gain, Elevated cholesterol levels, Elevated glucose levels, Elevated triglyceride levels, Glucosuria, Increased appetite, Development or exacerbation of diabetes occasionally associated with ketoacidosis or coma, including some fatal cases, Hypothermia.
Nervous system disorders: Somnolence, Dizziness, Akathisia, Parkinsonism, Dyskinesia, Seizures where in most cases a history of seizures or risk factors for seizures were reported, Dystonia (including oculogyration), Tardive dyskinesia, Amnesia, Dysarthria, Neuroleptic malignant syndrome, Discontinuation symptoms (Acute symptoms such as sweating, insomnia, tremor, anxiety, nausea and vomiting).
Cardiac disorders: Bradycardia, QTc prolongation, Ventricular tachycardia/ fibrillation, sudden death.
Vascular disorders: Orthostatic hypotension, Thromboembolism (including pulmonary embolism and deep vein thrombosis).
Respiratory, thoracic and mediastinal disorders: Epistaxis Gastrointestinal disorders: Mild, transient anticholinergic effects including constipation and dry mouth, Abdominal distension, Pancreatitis.
Hepatobiliary disorders: Transient, asymptomatic elevations of hepatic aminotransferases (ALT, AST), especially in early treatment, Hepatitis (including hepatocellular, cholestasis or mixed liver injury).
Skin and subcutaneous tissue disorders: Rash, Photosensitivity reaction, Alopecia.
Musculoskeletal and connective tissue disorders: Arthralgia, Rhabdomyolysis.
Renal and urinary disorders: Urinary incontinence, urinary retention, Urinary hesitation.
Reproductive system and breast disorders: Erectile dysfunction in males, Decreased libido in males and females, Amenorrhea, Breast enlargement, Galactorrhea in females, Gynaecomastia/ breast enlargement in males, Priapism.
General disorders and administration site conditions: Asthenia, Fatigue, Oedema, Pyrexia.
Investigations: Elevated plasma prolactin levels, increased alkaline phosphatase, High creatine phosphokinase, High Gamma Glutamyltransferase, High mic acid.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in